Globus Medical, Inc. Class A Common Stock (GMED)
92.72
-0.40 (-0.43%)
Globus Medical Inc is a medical device company that specializes in the development and commercialization of innovative products for spine surgery
The company focuses on creating solutions that enhance surgical outcomes and improve patient recovery through advanced technologies, including surgical implants, instruments, and robotics. With a robust portfolio, Globus Medical aims to address various spinal conditions and assist healthcare professionals in providing effective treatment options, ultimately striving to elevate the standard of care in spine surgery.
Why NYSE:GMED is Poised for High Growth.chartmill.com
A fundamental and technical analysis of (NYSEGMED): Exploring GLOBUS MEDICAL INC - A NYSE:GMEDNYSEGMED)
Via Chartmill · January 29, 2025
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025investors.com
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.
Via Investor's Business Daily · January 13, 2025
Inspire Medical's Sleep Innovations Driving Big Gainsinvestors.com
Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81.
Via Investor's Business Daily · January 8, 2025
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devicesinvestors.com
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.
Via Investor's Business Daily · January 7, 2025
Why GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock.chartmill.com
Delving into GLOBUS MEDICAL INC - A (NYSEGMED)'s high Growth Prospects.
Via Chartmill · December 31, 2024
Should you consider GLOBUS MEDICAL INC - A (NYSE:GMED) for high growth investing?chartmill.com
Unlocking the high Growth Potential of GLOBUS MEDICAL INC - A (NYSEGMED).
Via Chartmill · December 10, 2024
Novocure Stock Earns 96 RS Ratinginvestors.com
On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73.
Via Investor's Business Daily · December 3, 2024
Evaluating Globus Medical: Insights From 11 Financial Analystsbenzinga.com
Via Benzinga · December 2, 2024
Inari Medical Stock Gets RS Rating Upgradeinvestors.com
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.
Via Investor's Business Daily · December 11, 2024
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukosbenzinga.com
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via Benzinga · December 2, 2024
Despite its growth, NYSE:GMED remains within the realm of affordability.chartmill.com
GLOBUS MEDICAL INC - A (NYSEGMED) stands out as a growth opportunity that won't break the bank.
Via Chartmill · November 7, 2024
Globus Medical (GMED) Q3 2024 Earnings Call Transcriptfool.com
GMED earnings call for the period ending September 30, 2024.
Via The Motley Fool · November 5, 2024
The Analyst Verdict: Globus Medical In The Eyes Of 7 Expertsbenzinga.com
Via Benzinga · October 14, 2024
NYSE:GMED is showing good growth, while it is not too expensive.chartmill.com
In the world of growth stocks, NYSE:GMED shines as a value proposition.
Via Chartmill · October 2, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 6, 2024
CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesdaybenzinga.com
Via Benzinga · November 6, 2024
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · September 23, 2024
While growth is established for NYSE:GMED, the stock's valuation remains reasonable.chartmill.com
While growth is established for NYSE:GMED, the stock's valuation remains reasonable.
Via Chartmill · September 11, 2024
A Glimpse Into The Expert Outlook On Globus Medical Through 8 Analystsbenzinga.com
Via Benzinga · August 28, 2024
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.chartmill.com
GLOBUS MEDICAL INC - A (NYSEGMED) stands out as a growth opportunity that won't break the bank.
Via Chartmill · August 21, 2024